Publications by authors named "Mark Wise"

Claim this Profile
T
Trends in In Vitro Susceptibility to Ceftolozane/Tazobactam in Latin America: SMART Surveillance Program, 2016-2024.
Mark G Wise, James A Karlowsky, Thales J Polis, Fakhar Siddiqui, Katherine Young

Antibiotics (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018-2022 Global Surveillance.
C Andrew DeRyke, Mark G Wise, Karri A Bauer, Fakhar Siddiqui, Katherine Young

J Pediatric Infect Dis Soc· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22.
James A Karlowsky, Mark G Wise, Meredith A Hackel, David A Six, Tsuyoshi Uehara

J Antimicrob Chemother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of Gram-negative pathogens collected in Israel to ceftolozane/tazobactam, imipenem/relebactam and comparators: SMART 2018-22.
Mark G Wise, C Andrew DeRyke, Irina Alekseeva, Fakhar Siddiqui, Katherine Young

JAC Antimicrob Resist· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022.
Mark G Wise, James A Karlowsky, Naglaa Mohamed, Elizabeth D Hermsen, Shweta Kamat

J Glob Antimicrob Resist· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents - SMART 2018-2021.
Mark G Wise, James A Karlowsky, Wei-Ting Chen, Fakhar Siddiqui, Katherine Young

J Formos Med Assoc· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
activity of ceftazidime-avibactam and comparators against OXA-48-like Enterobacterales collected between 2016 and 2020.
Gregory Stone, Mark Wise, Eric Utt

Microbiol Spectr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents-SMART 2018-21.
James A Karlowsky, Mark G Wise, Wei-Ting Chen, Fakhar Siddiqui, Katherine Young

JAC Antimicrob Resist· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017-2021.
Mark G Wise, James A Karlowsky, Meredith A Hackel, Mohamed Amine Harti, Bontle M E Ntshole

J Glob Antimicrob Resist· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan-SMART 2012-2021.
James A Karlowsky, Mark G Wise, Tai-Chin Hsieh, Hung-Chi Lu, Wei-Ting Chen

J Glob Antimicrob Resist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of aztreonam-avibactam against Enterobacterales isolates collected in Latin America, Africa/Middle East, Asia, and Eurasia for the ATLAS Global Surveillance Program in 2019-2021.
Mark G Wise, James A Karlowsky, Naglaa Mohamed, Shweta Kamat, Daniel F Sahm

Eur J Clin Microbiol Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014-2019.
Mark G Wise, James A Karlowsky, Meredith A Hackel, Miki Takemura, Yoshinori Yamano

Microb Drug Resist· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of cefiderocol against MBL-producing Gram-negative bacteria collected in North America and Europe in five consecutive annual multinational SIDERO-WT surveillance studies (2014-2019).
Miki Takemura, Mark G Wise, Meredith A Hackel, Daniel F Sahm, Yoshinori Yamano

J Antimicrob Chemother· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019.
Ana C Gales, Gregory Stone, Daniel F Sahm, Mark G Wise, Eric Utt

J Antimicrob Chemother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020.
Mark G Wise, James A Karlowsky, Elkin V Lemos-Luengas, Rafael R Valdez, Daniel F Sahm

Braz J Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program.
James A Karlowsky, Meredith A Hackel, Mark G Wise, David A Six, Tsuyoshi Uehara

Antimicrob Agents Chemother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceftibuten-Ledaborbactam Activity against Multidrug-Resistant and Extended-Spectrum-β-Lactamase-Positive Clinical Isolates of from a 2018-2020 Global Surveillance Collection.
James A Karlowsky, Mark G Wise, Meredith A Hackel, Daniel C Pevear, Greg Moeck

Antimicrob Agents Chemother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates.
Patricia J Simner, Kimberlee A Musser, Kara Mitchell, Mark G Wise, Shawna Lewis

J Clin Microbiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization of clinical isolates of Enterobacterales with elevated MIC values for aztreonam-avibactam from the INFORM global surveillance study, 2012-2017.
Mark Estabrook, Krystyna M Kazmierczak, Mark Wise, Francis F Arhin, Gregory G Stone

J Glob Antimicrob Resist· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter evaluation of the RAPIDEC® CARBA NP assay for the detection of carbapenemase production in clinical isolates of Enterobacterales and Pseudomonas aeruginosa.
Allison R McMullen, Meghan A Wallace, Vincent LaBombardi, Janet Hindler, Shelley Campeau, Mark G Wise

Eur J Clin Microbiol Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth and Reproductive Performance of Rangeland Beef-Cattle as Influenced by Controlled and Uncontrolled Populations of Horn Flies (Diptera: Muscidae).
Brandon G Smythe, Mark E Wise, Andres F Cibils, Dawn VanLeeuwen, Adam F Summers

J Econ Entomol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study).
Krystyna M Kazmierczak, Masakatsu Tsuji, Mark G Wise, Meredith Hackel, Yoshinori Yamano

Int J Antimicrob Agents· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.
Mark G Wise, Mark A Estabrook, Daniel F Sahm, Gregory G Stone, Krystyna M Kazmierczak

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Mark G Wise, Elizabeth Horvath, Katherine Young, Daniel F Sahm, Krystyna M Kazmierczak

J Med Microbiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A LETTER FROM THE DMU WHITE COAT CEREMONY.
Mark Wise

Iowa Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis